A severe case of rhabdomyolysis after Moderna <scp>mRNA anti‐COVID</scp>‐19 vaccine with a literature review
Maria Sheka, Yann Coattrenec, Kuntheavy Ing Lorenzini, Mathieu Nendaz
Abstract
The identification of rhabdomyolysis as a potential fatal adverse reaction to recent COVID-19 vaccines is essential. As the symptoms of rhabdomyolysis are not specific, the threshold to actively search for this complication should be low.
Topics & Concepts
RhabdomyolysisMedicineCoronavirus disease 2019 (COVID-19)ComplicationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakAdverse effectVirologyIntensive care medicineInternal medicineOutbreakDiseaseInfectious disease (medical specialty)Muscle and Compartmental DisordersMechanical Circulatory Support DevicesSARS-CoV-2 and COVID-19 Research